Litcius/Paper detail

C-Reactive Protein, Chemerin, Fetuin-A and Osteopontin as Predictors of Cardiovascular Risks in Persons With Psoriasis Vulgaris

Pavel Borský, Zdeněk Fiala, Ctirad Andrýs, Martin Beránek, Květoslava Hamáková, Jan Kremláček, Andrea Málková, Tereza Švadláková, Jan Krejsek, Vladimír Palička, Vít Řeháček, Lenka Kotingová, Lenka Borská

2021Physiological Research14 citationsDOIOpen Access PDF

Abstract

The study aimed to contribute to understanding the role of CRP, chemerin, fetuin-A and osteopontin and to assess their suitability as biomarkers of early stages of cardiovascular diseases in psoriasis vulgaris. Serum levels measured in 28 patients and 22 controls. Patients: increased levels of CRP (p<0.001), chemerin (p<0.05), osteopontin (p<0.05) and decreased levels of fetuin-A (p<0.05), significant relationships between CRP and fetuin-A (rho=0.530, p<0.01), CRP and chemerin (rho=0.543, p<0.01), CRP and age (rho=0.590, p<0.001), osteopontin and fetuin-A (r=-0.415, p<0.05), chemerin and PASI score (rho=-0.424, p<0.05). We confirmed specific roles of the biomarkers in psoriasis. CRP, fetuin-A and osteopontin could be considered appropriate markers for the detection of early stages of cardiovascular diseases.

Topics & Concepts

OsteopontinChemerinFetuinInternal medicineMedicineEndocrinologyC-reactive proteinPsoriasisGastroenterologyInflammationImmunologyBiologyBiochemistryObesityAdipokineInsulin resistanceGlycoproteinVitamin D Research StudiesPsoriasis: Treatment and PathogenesisTherapeutic Uses of Natural Elements